Stay updated on Induction TPN, Nivolumab, Radiation in Larynx/Hypopharynx Clinical Trial
Sign up to get notified when there's something new on the Induction TPN, Nivolumab, Radiation in Larynx/Hypopharynx Clinical Trial page.

Latest updates to the Induction TPN, Nivolumab, Radiation in Larynx/Hypopharynx Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now includes a Locations section listing Georgia, Massachusetts, Missouri, and New York, with location entries reorganized under this section.SummaryDifference0.5%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page footer shows a new site revision: v3.3.2, replacing the previous v3.3.1. This appears to be a minor administrative update with no impact on the study details, eligibility criteria, or content presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; the visible study details and criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedThe government funding lapse notice has been removed from the page, and the study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedNo significant changes were detected between the two screenshots; the page content and study details appear unchanged.SummaryDifference0.4%

- Check95 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

Stay in the know with updates to Induction TPN, Nivolumab, Radiation in Larynx/Hypopharynx Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Induction TPN, Nivolumab, Radiation in Larynx/Hypopharynx Clinical Trial page.